CareLit · DOI-Nachweis · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2–6 years in Germany
DOI 10.1007/s00103-013-1844-9
Bibliografische Angaben
Nachweis in CareLit
Autor:innenFalkenhorst, G.; Harder, T.; Remschmidt, C.; Terhardt, M.; Zepp, F.; Ledig, T.; Wicker, S.; Keller-Stanislawski, B.; Mertens, T.
ZeitschriftBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Ausgabe10/2013
Jahrgang / SeitenJg. 56 · S. 1557 bis 1564
Kernaussage aus der Literatur
Abstract-Vorschau
The German Standing Committee on Vaccination (STIKO) recommends seasonal influenza vaccination for children and adolescents with chronic medical conditions that put them at risk for severe influenza illness. In addition to trivalent inactivated influenza vaccines (TIV), a trivalent live-attenuated influenza vaccine (LAIV) was licensed for children and adolescents aged 2–17 years in the European Union in 2011. Employ…
Zitieren
Zitierempfehlung
Falkenhorst, G.; Harder, T.; Remschmidt, C.; Terhardt, M.; Zepp, F.; Ledig, T.; Wicker, S.; Keller-Stanislawski, B.; Mertens, T (2013) Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2–6 years in Germany. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 56 (10), 1557 bis 1564. https://doi.org/10.1007/s00103-013-1844-9
Mit CareLit weiterarbeiten